All SEC Filings :: Avalo Therapeutics, Inc. (AVTX)

Filing Type:

Year:

Date	Form	Description	Pages
12/05/19	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Documents EX-2.1 EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-99.1	134
11/14/19	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1	85
11/14/19	8-K	Current report filing Documents EX-99.1	9
11/07/19	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	10
11/04/19	8-K	Current report filing Documents EX-2.1 EX-10.1 EX-10.2 EX-99.1	34
10/25/19	424B3	Prospectus filed pursuant to Rule 424(b)(3)	15
10/24/19	EFFECT	Notice of Effectiveness	1
10/22/19	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
10/21/19	4	Statement of changes in beneficial ownership of securities	2
10/18/19	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	3